Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Individual and Community Factors Associated With Detectable and Elevated Blood Lead in US Children: Results From a National Clinical Laboratory

PriMed 2021
Boston, MA, December 9-11, 2021

Poster presentation: Individual and Community Factors Associated With Detectable and Elevated Blood Lead in US Children: Results From a National Clinical Laboratory

Authors: Hauptman M, Niles JK, Gudin J, Kaufman HW

Specialties: Prescription Drug Monitoring, Toxicology, Pediatrics

Related content

Publication
Individual and Community-Level Factors Associated With Detectable and Elevated Blood Lead Levels in US Children: Results From a National Clinical Laboratory
Publication
Early Detection in Childhood Lead Exposure Relies on Timely Testing-Reply
Publication
Impact of the COVID-19 Pandemic on Blood Lead Testing in Children in the United States

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.